Exelon Patch 5
Exelon Patch 5 is a medicine authorised by Swissmedic under authorisation number 58078. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 December 2007 and the authorisation is valid without a time limit. ATC code N06DA03 places the medicine in the group Psychoanaleptics.
| Authorisation number | 58078 |
|---|---|
| Name | Exelon Patch 5 |
| Full name | Exelon Patch 5, transdermales Pflaster |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N06DA03 |
| First authorisation | 20 December 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Exelon Patch 5, transdermales Pflaster | B | 20 December 2007 |
| 2 | Exelon Patch 10, transdermales Pflaster | B | 20 December 2007 |
| 5 | Exelon Patch 15, transdermales Pflaster | B | 22 May 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Pflaster | N06DA03 | 01.99.0. | B |
| 3 | 30 | Pflaster | N06DA03 | 01.99.0. | B |
| 4 | 60 | Pflaster | N06DA03 | 01.99.0. | B |
| 5 | 30 | Pflaster | N06DA03 | 01.99.0. | B |
| 6 | 60 | Pflaster | N06DA03 | 01.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Exelon Patch 5 authorised in Switzerland?
Yes. Exelon Patch 5 is authorised by Swissmedic under authorisation number 58078, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Exelon Patch 5 have?
Exelon Patch 5 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Exelon Patch 5?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.